NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,848,834 | -9.0% | 832,742 | +0.1% | 0.06% | -5.2% |
Q2 2023 | $40,482,687 | -13.9% | 831,950 | -1.8% | 0.06% | -17.1% |
Q1 2023 | $47,024,774 | +38.3% | 846,988 | +0.0% | 0.07% | +29.6% |
Q4 2022 | $34,012,863 | -4.7% | 846,723 | +4.0% | 0.05% | -8.5% |
Q3 2022 | $35,686,000 | +8.0% | 814,385 | -9.2% | 0.06% | +18.0% |
Q2 2022 | $33,054,000 | -14.8% | 896,514 | -4.3% | 0.05% | -2.0% |
Q1 2022 | $38,817,000 | -31.0% | 936,482 | +55.5% | 0.05% | -30.1% |
Q4 2021 | $56,239,000 | -2.5% | 602,196 | +16.4% | 0.07% | -18.0% |
Q3 2021 | $57,661,000 | -6.3% | 517,415 | -4.6% | 0.09% | +15.6% |
Q2 2021 | $61,561,000 | +169.9% | 542,243 | +141.3% | 0.08% | +156.7% |
Q1 2021 | $22,813,000 | -52.0% | 224,675 | -52.9% | 0.03% | -9.1% |
Q4 2020 | $47,514,000 | +121.1% | 477,432 | +57.3% | 0.03% | -2.9% |
Q3 2020 | $21,485,000 | +57.0% | 303,541 | +10.6% | 0.03% | +36.0% |
Q2 2020 | $13,688,000 | – | 274,532 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |